Condition: ART · Pre-Eclampsia · Sponsor: University Hospital, Toulouse
This study seeks to validate the hypothesis that nulliparous pregnant women after Assisted Reproductive Technology (ART) are at high risk of preeclampsia and perinatal complications and represent a subgroup for which aspirin prophylaxis during pregnancy may be effective in the prevention of preterm preeclampsia and other perinatal adverse outcomes.
This description comes directly from the study's public registry record.
Paul GUERBY, MD · 5 67 77 12 33 · guerby.p@chu-toulouse.fr
Delphine DUCHANOIS, Midwife · 5 67 77 12 33 · duchanois.d@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| CHU Angers | Angers, France | Recruiting |
| CHU Bordeaux | Bordeaux, France | Recruiting |
| CHU Clermont-Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU Dijon-Bourgogne | Dijon, France | Recruiting |
| CHU Lille | Lille, France | Recruiting |
| HCL - Groupement Hospitalier Est, Hôpital Femme Mère Enfant | Lyon, France | Recruiting |
| AP-HM Hôpital de la Conception | Marseille, France | Recruiting |
| AP-HM Hôpital Nord | Marseille, France | Recruiting |
| CHU Montpellier | Montpellier, France | Recruiting |
| CHRU Nancy | Nancy, France | Recruiting |
| CHU Nantes | Nantes, France | Recruiting |
| CHU Nîmes | Nîmes, France | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05625724